comparemela.com

Latest Breaking News On - Zentalis pharmaceuticals stock down - Page 1 : comparemela.com

Zentalis Pharmaceuticals (NASDAQ:ZNTL) Sets New 12-Month Low at $9.48

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) hit a new 52-week low on Wednesday . The company traded as low as $9.48 and last traded at $9.59, with a volume of 536323 shares changing hands. The stock had previously closed at $9.99. Wall Street Analyst Weigh In A number of research firms recently weighed […]

Diana-hausman
Stifel-nicolaus
Zentalis-pharmaceuticals-inc
News-ratings-for-zentalis-pharmaceuticals-daily
Zentalis-pharmaceuticals-company-profile
Nasdaq
Decheng-capital
Vanguard-group-inc
Pricet-rowe-associates-inc
Zentalis-pharmaceuticals-stock-down
Institutional-trading-of-zentalis-pharmaceuticals
Hermes-inc

Zentalis Pharmaceuticals (NASDAQ:ZNTL) Sets New 12-Month Low at $9.48

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) hit a new 52-week low on Wednesday . The company traded as low as $9.48 and last traded at $9.59, with a volume of 536323 shares changing hands. The stock had previously closed at $9.99. Wall Street Analyst Weigh In A number of research firms recently weighed […]

Diana-hausman
Stifel-nicolaus
Zentalis-pharmaceuticals-stock-down
Zentalis-pharmaceuticals-inc
Vanguard-group-inc
Pricet-rowe-associates-inc
Decheng-capital
Nasdaq
Zentalis-pharmaceuticals
Eventide-asset-management
Zentalis-pharmaceuticals-company-profile
Hermes-inc

abrdn plc Makes New Investment in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL)

Abrdn plc purchased a new stake in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 40,156 shares of the company’s stock, valued at approximately $608,000. abrdn plc owned about 0.06% of Zentalis Pharmaceuticals as […]

Melissab-epperly
Exchange-commission
Hermes-inc
Insider-transactions-at-zentalis-pharmaceuticals
News-ratings-for-zentalis-pharmaceuticals-daily
Eventide-asset-management
Sectoral-asset-management-inc
Quarter-for-zentalis-pharmaceuticals
Vanguard-group-inc
Zentalis-pharmaceuticals-stock-down
Nasdaq

Zentalis Pharmaceuticals (NASDAQ:ZNTL) Trading Down 7.1%

Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) fell 7.1% during mid-day trading on Wednesday . The company traded as low as $11.63 and last traded at $11.68. 445,154 shares were traded during mid-day trading, a decline of 44% from the average session volume of 791,847 shares. The stock had previously closed at […]

Wellington
New-zealand-general
New-zealand
Melissab-epperly
Eventide-asset-management
Hermes-inc
Zentalis-pharmaceuticals
Zentalis-pharmaceuticals-inc
Zentalis-pharmaceuticals-stock-down
Wellington-management-group
Institutional-trading-of-zentalis-pharmaceuticals

Zentalis Pharmaceuticals (NASDAQ:ZNTL) Trading Up 6.3%

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report)’s stock price was up 6.3% during mid-day trading on Tuesday . The company traded as high as $15.66 and last traded at $15.54. Approximately 105,881 shares changed hands during trading, a decline of 87% from the average daily volume of 796,470 shares. The stock had previously closed […]

China
Melissab-epperly
News-ratings-for-zentalis-pharmaceuticals-daily
Zentalis-pharmaceuticals-stock-down
Quest-partners
Us-bancorp
Securities-exchange-commission
Zentalis-pharmaceuticals
Zentalis-pharmaceuticals-inc
Institutional-investors-weigh-in-on-zentalis-pharmaceuticals
China-universal-asset-management-co

vimarsana © 2020. All Rights Reserved.